Spyre Therapeutics Inc (SYRE)

Accounts Payable

$5.72M

Quarterly · Period ending: · USD

SYRE logo

SYRE Accounts Payable

Latest reported$5.72M
SYRE Quarterly Accounts Payable ($345.00K → $5.72M)
High-resolution chart · PNG

SYRE accounts payable history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Accounts Payable — Quarterly (USD)
Period endingAccounts Payable (USD)
5,722,000
5,692,000
8,904,000
7,457,000
3,712,000
3,689,000
666,000
5,165,000
3,231,000
3,106,000
896,000
1,678,000
2,854,000
2,062,000
677,000
4,178,000
1,958,000
2,981,000
3,319,000
1,863,000
2,221,000
1,878,000
2,254,000
2,295,000
4,151,000
3,618,000
3,154,000
2,431,000
2,724,000
3,223,000
663,000
1,077,000
952,000
763,000
389,000
615,000
634,000
267,000
168,000
523,000
348,000
509,000
176,000
562,000
1,109,000
290,000
345,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.